Want to create an interactive transcript for this episode?
Podcast: Faith and Economics
Episode: Oh Oh No Ozempic? | #385
Description: A new class of drugs, GLP-1 inhibitors (Ozempic being the most recognizable) has seemingly taken the world by storm. If the hype is to be believed, there seems to be enormous upsides and zero downsides to these new wonders of chemistry. Is that really the case, or might there be reason for caution? Join the Gwartney Institute for an insightful discussion on the promise and perils of these powerful peptides.